SEC Form 4 · accession 0001181431-15-004771
ZOGENIX, INC. · ZGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradley S. Galer
Officer — Chief Medical Officer
Period of report
Mar 17, 2015
Accepted (ET)
Mar 17, 2015 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001375151
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Right to buyF1 | $1.33 | Mar 17, 2015 | A | 225,000 | A | — | Mar 17, 2025 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F1The option was granted on March 17, 2015 and vests in a series of forty-eight (48) successive, equal monthly installments beginning on March 17, 2015, subject to the reporting person's continued employment with the company on each such vesting date.